Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg

Company Announcement Date: June 02, 2020

FDA Publish Date: June 05, 2020

Product Type: Drugs

Reason for Announcement:Due to detection of N-Nitrosodimethylamine (NDMA)

Company Name:Teva Pharmaceuticals USA Inc.

Brand Name:Actavis

Product Description:Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg